Imugene and Kincell Bio Announce Strategic Manufacturing and Process Development Partnership Kincell Bio to acquire Imugene’s North Carolina manufacturing facility for up to $6M USD in upfront and milestone-driven payments over three yearsKincell will expand its capacity and commitment to...

Kincell Bio Launches with $36M to Make Cell Therapy Development and Manufacturing Accessible for Early-Stage Innovators Cell therapy CDMO spins out of Inceptor Bio to help innovators develop and manufacture life-saving cell therapies Kincell to be led by CEO Dr. Bruce Thompson Shailesh Maingi, founder of Kineticos...